Clinical Trial Update: Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating EVO100 for prevention of urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infections has completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chlamydia Trachomatis Infection
• Neisseria Gonorrhoeae Infection

Drugs mentioned

• EVO100

Snippet

Sponsor: Evofem Inc. | Conditions: Sexually Transmitted Diseases, Gonorrhea | Phase 3 | Status: COMPLETED | Results posted: 2024-01-30